Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Transact Technologies (TACT) Research & Development (2016 - 2025)

Transact Technologies' Research & Development history spans 15 years, with the latest figure at $1.6 million for Q4 2024.

  • For Q4 2024, Research & Development fell 27.19% year-over-year to $1.6 million; the TTM value through Dec 2024 reached $7.0 million, down 26.11%, while the annual FY2024 figure was $7.0 million, 26.11% down from the prior year.
  • Research & Development for Q4 2024 was $1.6 million at Transact Technologies, down from $1.6 million in the prior quarter.
  • Across five years, Research & Development topped out at $2.5 million in Q3 2023 and bottomed at $1.4 million in Q2 2020.
  • The 5-year median for Research & Development is $1.8 million (2021), against an average of $1.9 million.
  • The largest annual shift saw Research & Development soared 40.49% in 2020 before it crashed 34.64% in 2024.
  • A 5-year view of Research & Development shows it stood at $1.5 million in 2020, then soared by 33.93% to $2.0 million in 2021, then rose by 7.68% to $2.2 million in 2022, then dropped by 0.6% to $2.2 million in 2023, then dropped by 27.19% to $1.6 million in 2024.
  • Per Business Quant, the three most recent readings for TACT's Research & Development are $1.6 million (Q4 2024), $1.6 million (Q3 2024), and $1.8 million (Q2 2024).